Cargando…
The MyD88+ Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer
The prognosis of epithelial ovarian cancer is poor in part due to the high frequency of chemoresistance. Recent evidence points to the Toll-like receptor-4 (TLR4), and particularly its adaptor protein MyD88, as one potential mediator of this resistance. This study aims to provide further evidence th...
Autores principales: | d'Adhemar, Charles J., Spillane, Cathy D., Gallagher, Michael F., Bates, Mark, Costello, Katie M., Barry-O'Crowley, Jacqui, Haley, Kathryn, Kernan, Niamh, Murphy, Ciara, Smyth, Paul C., O'Byrne, Ken, Pennington, Stephen, Cooke, Aoife A., Ffrench, Brendan, Martin, Cara M., O'Donnell, Dearbhaile, Hennessy, Bryan, Stordal, Britta, Finn, Stephen, McCann, Amanda, Gleeson, Noreen, D'Arcy, Tom, Flood, Brian, O'Neill, Luke A. J., Sheils, Orla, O'Toole, Sharon, O'Leary, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076208/ https://www.ncbi.nlm.nih.gov/pubmed/24977712 http://dx.doi.org/10.1371/journal.pone.0100816 |
Ejemplares similares
-
Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening
por: Laios, Alexandros, et al.
Publicado: (2013) -
Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade
por: Cluxton, Christopher D., et al.
Publicado: (2019) -
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
por: McEvoy, Lynda M., et al.
Publicado: (2015) -
An integrative model for recurrence in ovarian cancer
por: Laios, Alexandros, et al.
Publicado: (2008) -
CD10(−)/ALDH(−) cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy
por: Ffrench, Brendan, et al.
Publicado: (2017)